TERB2
gene geneOn this page
Also known as MGC33951
Summary
TERB2 (telomere repeat binding bouquet formation protein 2, HGNC:28520) is a protein-coding gene on chromosome 15q21.1, encoding Telomere repeats-binding bouquet formation protein 2 (Q8NHR7). Meiosis-specific telomere-associated protein involved in meiotic telomere attachment to the nucleus inner membrane, a crucial step for homologous pairing and synapsis.
Predicted to be involved in homologous chromosome pairing at meiosis and meiotic attachment of telomere to nuclear envelope. Predicted to act upstream of or within meiosis I; oogenesis; and spermatogenesis. Predicted to be located in chromosome, telomeric region. Predicted to be active in nuclear inner membrane. Implicated in spermatogenic failure 59.
Source: NCBI Gene 145645 — RefSeq curated summary.
At a glance
- Gene–disease (curated): spermatogenic failure 59 (Moderate, GenCC)
- Clinical variants (ClinVar): 13 total — 2 pathogenic, 1 likely-pathogenic
- Phenotypes (HPO): 11
- MANE Select transcript:
NM_152448
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28520 |
| Approved symbol | TERB2 |
| Name | telomere repeat binding bouquet formation protein 2 |
| Location | 15q21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC33951 |
| Ensembl gene | ENSG00000167014 |
| Ensembl biotype | protein_coding |
| OMIM | 617131 |
| Entrez | 145645 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 nonsense_mediated_decay, 1 protein_coding
ENST00000340827, ENST00000557864, ENST00000559137
RefSeq mRNA: 1 — MANE Select: NM_152448
NM_152448
CCDS: CCDS10115
Canonical transcript exons
ENST00000340827 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001140454 | 44956896 | 44956977 |
| ENSE00001182995 | 44956687 | 44956782 |
| ENSE00001380316 | 44978489 | 44979229 |
| ENSE00003469541 | 44966158 | 44966243 |
| ENSE00003549113 | 44961523 | 44961584 |
| ENSE00003576450 | 44973867 | 44973955 |
| ENSE00003646400 | 44958373 | 44958512 |
Expression profiles
Bgee: expression breadth broad, 29 present calls, max score 87.27.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1131 / max 108.7115, expressed in 5 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 146417 | 0.1096 | 5 |
| 207494 | 0.0035 | 2 |
Top tissues by expression
237 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.27 | gold quality |
| right testis | UBERON:0004534 | 83.04 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.63 | gold quality |
| left testis | UBERON:0004533 | 82.32 | gold quality |
| testis | UBERON:0000473 | 80.99 | gold quality |
| adult organism | UBERON:0007023 | 60.46 | silver quality |
| sperm | CL:0000019 | 58.47 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 53.81 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| pancreatic ductal cell | CL:0002079 | 53.08 | silver quality |
| right lobe of liver | UBERON:0001114 | 53.06 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| liver | UBERON:0002107 | 47.12 | gold quality |
| ileal mucosa | UBERON:0000331 | 47.11 | silver quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| quadriceps femoris | UBERON:0001377 | 46.49 | gold quality |
| tibialis anterior | UBERON:0001385 | 46.48 | silver quality |
| deltoid | UBERON:0001476 | 46.29 | gold quality |
| skin of hip | UBERON:0001554 | 45.87 | silver quality |
| vastus lateralis | UBERON:0001379 | 45.40 | gold quality |
| upper leg skin | UBERON:0004262 | 45.33 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 44.92 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 43.99 | gold quality |
| oviduct epithelium | UBERON:0004804 | 43.65 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 43.55 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| sural nerve | UBERON:0015488 | 43.08 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.44 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
47 targeting TERB2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-6715A-3P | 99.83 | 68.05 | 1473 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
| HSA-MIR-4668-5P | 99.79 | 70.58 | 3782 |
| HSA-MIR-4517 | 99.76 | 69.19 | 1867 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-1179 | 99.71 | 68.70 | 1040 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-580-3P | 99.67 | 69.23 | 1841 |
| HSA-MIR-3685 | 99.62 | 68.83 | 1621 |
| HSA-MIR-451B | 99.55 | 68.28 | 1380 |
| HSA-MIR-510-3P | 99.54 | 70.06 | 2965 |
| HSA-MIR-5584-5P | 99.49 | 68.22 | 2814 |
Literature-anchored findings (GeneRIF, showing 3)
- complementary structured illumination microscopy studies and biochemical findings reveal a telomere attachment mechanism in which MAJIN-TERB2-TERB1 recruits telomere-bound TRF1, which is then displaced during pachytene, allowing MAJIN-TERB2-TERB1 to bind telomeric DNA and form a mature attachment plate. (PMID:30559341)
- The meiotic TERB1-TERB2-MAJIN complex tethers telomeres to the nuclear envelope (PMID:30718482)
- Disruption of human meiotic telomere complex genes TERB1, TERB2 and MAJIN in men with non-obstructive azoospermia. (PMID:33211200)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:dkey-1h4.5 | ENSDARG00000039477 |
| mus_musculus | Terb2 | ENSMUSG00000027229 |
| rattus_norvegicus | Terb2 | ENSRNOG00000037178 |
Protein
Protein identifiers
Telomere repeats-binding bouquet formation protein 2 — Q8NHR7 (reviewed: Q8NHR7)
All UniProt accessions (3): Q8NHR7, H0YKV2, H0YNH3
UniProt curated annotations — full annotation on UniProt →
Function. Meiosis-specific telomere-associated protein involved in meiotic telomere attachment to the nucleus inner membrane, a crucial step for homologous pairing and synapsis. Component of the MAJIN-TERB1-TERB2 complex, which promotes telomere cap exchange by mediating attachment of telomeric DNA to the inner nuclear membrane and replacement of the protective cap of telomeric chromosomes: in early meiosis, the MAJIN-TERB1-TERB2 complex associates with telomeric DNA and the shelterin/telosome complex. During prophase, the complex matures and promotes release of the shelterin/telosome complex from telomeric DNA.
Subunit / interactions. Component of the MAJIN-TERB1-TERB2 complex, composed of MAJIN, TERB1 and TERB2.
Subcellular location. Chromosome. Telomere. Nucleus inner membrane.
Disease relevance. Spermatogenic failure 59 (SPGF59) [MIM:619645] An autosomal recessive male infertility disorder characterized by non-obstructive azoospermia, due to sperm maturation arrest. The disease may be caused by variants affecting the gene represented in this entry.
Similarity. Belongs to the TERB2 family.
RefSeq proteins (1): NP_689661* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028065 | TERB2 | Family |
Pfam: PF15101
UniProt features (21 total): strand 9, helix 7, sequence variant 3, chain 1, turn 1
Structure
Experimental structures (PDB)
4 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6GNY | X-RAY DIFFRACTION | 1.85 |
| 6GNX | X-RAY DIFFRACTION | 2.9 |
| 6J08 | X-RAY DIFFRACTION | 2.9 |
| 6J07 | X-RAY DIFFRACTION | 3.3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NHR7-F1 | 70.93 | 0.45 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 107 (showing top):
GOBP_MEIOTIC_CHROMOSOME_SEGREGATION, GOBP_CHROMOSOME_ORGANIZATION, GOBP_CHROMOSOME_LOCALIZATION, GOBP_OOGENESIS, GOBP_MALE_GAMETE_GENERATION, GOBP_SYNAPTONEMAL_COMPLEX_ORGANIZATION, GOBP_ORGANELLE_FISSION, GOBP_DNA_DAMAGE_RESPONSE, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOTIC_CELL_CYCLE, GOBP_FEMALE_GAMETE_GENERATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_HOMOLOGOUS_CHROMOSOME_SEGREGATION, GOBP_MEIOTIC_CELL_CYCLE_PROCESS, GOBP_ORGANELLE_LOCALIZATION
GO Biological Process (7): homologous chromosome pairing at meiosis (GO:0007129), synaptonemal complex assembly (GO:0007130), spermatogenesis (GO:0007283), meiotic telomere clustering (GO:0045141), oogenesis (GO:0048477), meiotic attachment of telomere to nuclear envelope (GO:0070197), double-strand break repair involved in meiotic recombination (GO:1990918)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (7): chromosome, telomeric region (GO:0000781), nuclear envelope (GO:0005635), nuclear inner membrane (GO:0005637), nuclear membrane (GO:0031965), nucleus (GO:0005634), chromosome (GO:0005694), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| chromosome organization involved in meiotic cell cycle | 3 |
| meiotic cell cycle process | 2 |
| nucleus | 2 |
| homologous chromosome segregation | 1 |
| homologous chromosome pairing at meiosis | 1 |
| cellular component assembly | 1 |
| synaptonemal complex organization | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| telomere localization | 1 |
| chromosome localization to nuclear envelope involved in homologous chromosome segregation | 1 |
| germ cell development | 1 |
| female gamete generation | 1 |
| meiotic telomere tethering at nuclear periphery | 1 |
| chromosome attachment to the nuclear envelope | 1 |
| double-strand break repair | 1 |
| reciprocal meiotic recombination | 1 |
| binding | 1 |
| chromosomal region | 1 |
| endomembrane system | 1 |
| organelle envelope | 1 |
| organelle inner membrane | 1 |
| nuclear membrane | 1 |
| nuclear envelope | 1 |
| organelle membrane | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular membraneless organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
340 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TERB2 | TERB1 | Q8NA31 | 995 |
| TERB2 | H0YEC1 | H0YEC1 | 992 |
| TERB2 | TERF1 | P54274 | 858 |
| TERB2 | KASH5 | Q8N6L0 | 839 |
| TERB2 | SUN1 | O94901 | 826 |
| TERB2 | SPDYA | Q5MJ70 | 750 |
| TERB2 | SUN2 | Q9UH99 | 745 |
| TERB2 | HORMAD1 | Q86X24 | 547 |
| TERB2 | TINF2 | Q9BSI4 | 512 |
| TERB2 | HORMAD2 | Q8N7B1 | 512 |
| TERB2 | STAG3 | Q9UJ98 | 488 |
| TERB2 | SYCP3 | Q8IZU3 | 481 |
| TERB2 | OR2T5 | Q6IEZ7 | 480 |
| TERB2 | OR6T1 | Q8NGN1 | 474 |
| TERB2 | C14orf39 | Q8N1H7 | 452 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MAJIN | TERB2 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (2): C11orf85 (Two-hybrid), APP (Reconstituted Complex)
ESM2 similar proteins: A0A2R8VHF7, A0JM23, A2QRA0, A4IIA7, A4IIV4, A6NFN9, A6NHR9, A7MBF6, F4IG73, F4JSE7, O17482, O95876, P12540, P21784, P34089, P38899, P55895, P56696, Q08AW4, Q0D2D7, Q12789, Q13829, Q28DC9, Q2WGJ8, Q3E7Y5, Q3UUE9, Q4R907, Q4VXA5, Q5BK83, Q5EA90, Q5F476, Q5HZS2, Q5M9F0, Q5RAX4, Q5RBH4, Q5RD21, Q6AYL6, Q6DGA7, Q6PIY5, Q70XZ2
Diamond homologs: Q2M2T9, Q5BJD2, Q8NHR7, Q9D494
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| TERB2 | “form complex” | “TTM complex” | binding |
| TERB2 | “up-regulates activity” | “Cohesin complex” | relocalization |
Disease & clinical
Clinical variants and AI predictions
ClinVar
13 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 1 |
| Uncertain significance | 6 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (3)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1326957 | NM_152448.3(TERB2):c.457_458del (p.Thr153fs) | Pathogenic |
| 1326958 | NM_152448.3(TERB2):c.544dup (p.Met182fs) | Pathogenic |
| 1244236 | NM_152448.3(TERB2):c.434G>A (p.Ser145Asn) | Likely pathogenic |
SpliceAI
1040 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:44966152:CCACA:C | acceptor_loss | 1.0000 |
| 15:44966153:CACA:C | acceptor_loss | 1.0000 |
| 15:44966154:ACAG:A | acceptor_loss | 1.0000 |
| 15:44966155:CA:C | acceptor_loss | 1.0000 |
| 15:44966156:A:AC | acceptor_loss | 1.0000 |
| 15:44966156:A:AG | acceptor_gain | 1.0000 |
| 15:44966156:AGCAT:A | acceptor_gain | 1.0000 |
| 15:44966157:G:A | acceptor_loss | 1.0000 |
| 15:44966157:G:GA | acceptor_gain | 1.0000 |
| 15:44966157:GC:G | acceptor_gain | 1.0000 |
| 15:44966157:GCAT:G | acceptor_gain | 1.0000 |
| 15:44966157:GCATG:G | acceptor_gain | 1.0000 |
| 15:44958372:GAAT:G | acceptor_gain | 0.9900 |
| 15:44958441:T:TA | donor_gain | 0.9900 |
| 15:44958442:A:AA | donor_gain | 0.9900 |
| 15:44966157:GCA:G | acceptor_gain | 0.9900 |
| 15:44966239:AAAAG:A | donor_loss | 0.9900 |
| 15:44966240:AAAGG:A | donor_loss | 0.9900 |
| 15:44966242:AG:A | donor_loss | 0.9900 |
| 15:44966243:G:GA | donor_loss | 0.9900 |
| 15:44966245:T:C | donor_loss | 0.9900 |
| 15:44973952:ACAG:A | donor_gain | 0.9900 |
| 15:44978483:TTGTA:T | acceptor_loss | 0.9900 |
| 15:44978484:TGTA:T | acceptor_loss | 0.9900 |
| 15:44978485:GTAG:G | acceptor_loss | 0.9900 |
| 15:44978486:TAGG:T | acceptor_loss | 0.9900 |
| 15:44956973:CTGAG:C | donor_loss | 0.9800 |
| 15:44956974:TGAGG:T | donor_loss | 0.9800 |
| 15:44956977:GG:G | donor_loss | 0.9800 |
| 15:44956978:GT:G | donor_loss | 0.9800 |
AlphaMissense
1479 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:44956946:A:C | S39R | 0.991 |
| 15:44956948:C:A | S39R | 0.991 |
| 15:44956948:C:G | S39R | 0.991 |
| 15:44958414:T:A | V63D | 0.978 |
| 15:44961552:T:A | W106R | 0.978 |
| 15:44961552:T:C | W106R | 0.978 |
| 15:44956944:T:C | F38S | 0.977 |
| 15:44956743:T:C | F9L | 0.974 |
| 15:44956745:T:A | F9L | 0.974 |
| 15:44956745:T:G | F9L | 0.974 |
| 15:44956740:T:A | W8R | 0.973 |
| 15:44956740:T:C | W8R | 0.973 |
| 15:44956779:T:A | W21R | 0.973 |
| 15:44956779:T:C | W21R | 0.973 |
| 15:44958417:T:C | F64S | 0.964 |
| 15:44958482:T:C | F86L | 0.964 |
| 15:44958484:C:A | F86L | 0.964 |
| 15:44958484:C:G | F86L | 0.964 |
| 15:44956943:T:C | F38L | 0.963 |
| 15:44956945:C:A | F38L | 0.963 |
| 15:44956945:C:G | F38L | 0.963 |
| 15:44961554:G:C | W106C | 0.961 |
| 15:44961554:G:T | W106C | 0.961 |
| 15:44978539:T:C | F192L | 0.961 |
| 15:44978541:C:A | F192L | 0.961 |
| 15:44978541:C:G | F192L | 0.961 |
| 15:44958489:T:C | L88P | 0.957 |
| 15:44956722:T:C | F2L | 0.953 |
| 15:44956724:T:A | F2L | 0.953 |
| 15:44956724:T:G | F2L | 0.953 |
dbSNP variants (sampled 300 via entrez): RS1000485417 (15:44960253 T>C), RS1000714197 (15:44955017 A>C,G), RS1000737318 (15:44966856 A>C,T), RS1000766533 (15:44959897 C>T), RS1000936232 (15:44956699 T>C,G), RS1000988581 (15:44956917 G>T), RS1001121697 (15:44977368 T>C,G), RS1001123698 (15:44970745 A>T), RS1001278648 (15:44970009 AATG>A), RS1001394531 (15:44965355 C>T), RS1001401551 (15:44975708 A>G), RS1001402133 (15:44976031 A>C,G), RS1001469538 (15:44977115 A>C), RS1001596889 (15:44973920 C>G,T), RS1001649149 (15:44974289 C>T)
Disease associations
OMIM: gene MIM:617131 | disease phenotypes: MIM:619645
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| spermatogenic failure 59 | Moderate | Autosomal recessive |
Mondo (1): spermatogenic failure 59 (MONDO:0030492)
Orphanet (0):
HPO phenotypes
11 total (11 of 11 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000027 | Azoospermia |
| HP:0000118 | Phenotypic abnormality |
| HP:0000837 | Increased circulating gonadotropin level |
| HP:0003251 | Male infertility |
| HP:0008669 | Abnormal spermatogenesis |
| HP:0008734 | Decreased testicular size |
| HP:0011462 | Young adult onset |
| HP:0011961 | Non-obstructive azoospermia |
| HP:0011962 | Obstructive azoospermia |
| HP:0031038 | Spermatogenesis maturation arrest |
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases methylation | 1 |
| Methotrexate | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Antirheumatic Agents | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: spermatogenic failure 59
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): spermatogenic failure 59